Brepocitinib becomes first oral therapy approved for adult dermatomyositis
1. Brepocitinib is the first oral therapy specifically approved for adults with dermatomyositis, providing a disease-specific alternative to treatment strategies ...
Tag: autoimmune disease
![No benefit with hydroxychloroquine (Plaquenil) over placebo in Sjogren’s Syndrome [JOQUER Trial]](https://www.2minutemedicine.com/wp-content/uploads/2014/07/Sjogren_syndrome_2-350x250.jpg)
Iscalimab shows dose-dependent improvement among patients with active Sjögren’s disease
1. Isaclimab significantly improved disease activity at 150 mg and 600 mg doses. 2. Adverse events were comparable between cohorts ...
The 2 Minute Medicine Podcast Episode 25
Welcome to the 2 Minute Medicine Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this ...
The 2 Minute Medicine Podcast Episode 5
Welcome to the 2 Minute Medicine Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this ...
The 2 Minute Medicine Podcast Episode 1
Welcome to the 2 Minute Medicine Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this ...
The Scan by 2 Minute Medicine®: The Last Dance, Head of State, Trouble on the Farm and the Heart of COVID-19!
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. ...
Ruxolitinib results in improved repigmentation as compared to vehicle-control in nonsegmental vitiligo
1. In comparison to vehicle-control, a greater proportion of patients using ruxolitinib achieved a reduction in facial Vitiligo Area Scoring ...
The Scan by 2 Minute Medicine®: Tennis Legends, Sausage Fingers, Alopecia Awareness Month and Starbucks Recalls!
The Scan by 2 Minute Medicine® is a new pop-culture medical newsletter designed to bring a physician perspective to trending ...
Individuals with autoimmune diseases may have an increased risk for cardiovascular diseases
1. An increased incidence of new cardiovascular disease was seen in individuals with autoimmune disease compared to those without. 2. ...
Survival is similar for patients with autoimmune disease treated with immune checkpoint inhibitors compared to patients with no autoimmune disease
1. There was no significant difference in efficacy of ICIs in cancer patients with or without AID. 2. Immune-related toxic ...
